ReviewHeliyon2023
Optimal locations and computational frameworks of FSR and IMU sensors for measuring gait abnormalities.
Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 20 citations in OpenAlex.
- Freezing of Gait in Parkinson's Disease: A Scoping Review on the Path Towards Real-Time Therapies.Sensors (Basel, Switzerland) · 2026Article
- Keratinization-related gene signature predicting survival and response to radiation in patients with HPV-negative head and neck squamous cell carcinoma via regulation of cornification and integrin signaling.Cellular & molecular biology letters · 2026Article
- Gait Parameters of Women Before Knee Joint Arthritis-Analysis Using the MoKA System.Sensors (Basel, Switzerland) · 2025Article
- A deep learning pipeline for detecting vestibular schwannoma patients with unilateral vestibular loss based on kinematic data.Scientific reports · 2025Article
- Enhanced Reaction Time Measurement System Based on 3D Accelerometer in Athletics.Sensors (Basel, Switzerland) · 2025Article
- Monitoring Mobility at Home: The GAIT-HUB Sensor-Based Protocol for Remote Gait Analysis.Digital biomarkersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuromuscular diseases cause abnormal joint movements and drastically alter gait patterns in patients. The analysis of abnormal gait patterns can provide clinicians with an in-depth insight into implementing appropriate rehabilitation therapies. Wearable sensors are used to measure the gait patterns of neuromuscular patients due to their non-invasive and cost-efficient characteristics. FSR and IMU sensors are the most popular and efficient options. When assessing abnormal gait patterns, it is important to determine the optimal locations of FSRs and IMUs on the human body, along with their computational framework. The gait abnormalities of different types and the gait analysis systems based on IMUs and FSRs have therefore been investigated. After studying a variety of research articles, the optimal locations of the FSR and IMU sensors were determined by analysing the main pressure points under the feet and prime anatomical locations on the human body. A total of seven locations (the big toe, heel, first, third, and fifth metatarsals, as well as two close to the medial arch) can be used to measure gate cycles for normal and flat feet. It has been found that IMU sensors can be placed in four standard anatomical locations (the feet, shank, thigh, and pelvis). A section on computational analysis is included to illustrate how data from the FSR and IMU sensors are processed. Sensor data is typically sampled at 100 Hz, and wireless systems use a range of microcontrollers to capture and transmit the signals. The findings reported in this article are expected to help develop efficient and cost-effective gait analysis systems by using an optimal number of FSRs and IMUs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.